Susquehanna International Group, LLP Rockwell Medical, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.67 - $4.4 $437,039 - $1.15 Million	261,700 New	261,700 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$1.58 - $2.44 $2,370 - $3,660	1,500 Added 5.36%	29,500 $55,000
Q3 2023 Nov 14, 2023	SELL	$1.83 - $6.19 $26,535 - $89,755	-14,500 Reduced 34.12%	28,000 $58,000
Q2 2023 Aug 11, 2023	BUY	$1.8 - $5.46 $76,500 - $232,050	42,500 New	42,500 $232,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.11 $63,000 - $110,775	-52,500 Reduced 60.41%	34,400 $45,000
Q2 2022 Aug 15, 2022	BUY	$1.28 - $4.84 $111,232 - $420,596	86,900 New	86,900 $112,000

9.46M

339K

43.3K

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $25.2M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.